Crossmark

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

Published Online: 2021-06-30

Published Print: 2021-12

Authors

Iivanainen, Sanna

Ekstrom, Jussi

Virtanen, Henri

Kataja, Vesa V.

Koivunen, Jussi P.
License Information

Text and Data Mining valid from 2021-06-30

Version of Record valid from 2021-06-30
More Information

Article History

Received: 15 December 2020

Accepted: 22 June 2021

First Online: 30 June 2021

Declarations

:

: The study was approved by Pohjois-Pohjanmaan sairaanhoitopiiri (PPSHP) Ethics Committee (9/2017) and registered at the Clinical Trials Register with identifier code NCT03928938. All study subjects signed an informed consent to participate in the trial.

: Not appilicable.

: SI declares no competing interests. JE, HV, and VK are employees of Kaiku Health. JPK is an advisor for Kaiku Health.

Document is current